These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A comparison of five maintenance therapies for reflux esophagitis. Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948 [TBL] [Abstract][Full Text] [Related]
24. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259 [TBL] [Abstract][Full Text] [Related]
25. Esophageal motility and 24-h pH profiles of patients with heterotopic gastric mucosa in the cervical esophagus. Korkut E; Bektaş M; Alkan M; Ustün Y; Meco C; Ozden A; Soykan I Eur J Intern Med; 2010 Feb; 21(1):21-4. PubMed ID: 20122608 [TBL] [Abstract][Full Text] [Related]
26. Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials. Wiklund I; Carlsson R; Carlsson J; Glise H Scand J Gastroenterol; 2006 Mar; 41(3):288-93. PubMed ID: 16497615 [TBL] [Abstract][Full Text] [Related]
27. [Clinical analysis of 39 cases of heterotopic gastric mucosa in the upper esophagus]. Song ZY; Huang X; Qian KD; Peng JP; Sun AW; Zhang YY; Zhao ZG Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):244-7. PubMed ID: 15854485 [TBL] [Abstract][Full Text] [Related]
30. Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by early repeat endoscopy. Fasseas P; Leybishkis B; Rocca G Int J Clin Pract; 2001 Dec; 55(10):661-4. PubMed ID: 11777288 [TBL] [Abstract][Full Text] [Related]
31. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A; Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285 [TBL] [Abstract][Full Text] [Related]
37. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease. Størdal K; Johannesdottir GB; Bentsen BS; Knudsen PK; Carlsen KC; Closs O; Handeland M; Holm HK; Sandvik L Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133 [TBL] [Abstract][Full Text] [Related]
38. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153 [TBL] [Abstract][Full Text] [Related]